Urinary Incontinence Disease Summary

Last updated: 18 November 2024
Disease Summary

Content on this page:

Content on this page:

Overview

Urinary incontinence is the complaint of involuntary urine leakage.
Stress urinary incontinence is the involuntary urine leakage on effort or exertion or when coughing or sneezing.
Urge urinary incontinence is the one associated with or immediately preceded by urgency.
Mixed urinary incontinence is the involuntary urine leakage associated with both urgency and with exertion, effort, coughing or sneezing.
Antimuscarinic agents act mainly during the urinary storage phase, decreasing urge and increasing bladder capacity. All available antimuscarinic agents decrease the frequency of urgency and incontinence episodes effectively. Antimuscarinic therapy should be tried for 4-12 weeks to assess benefits and side effects.
Bladder retraining may be offered as a first line treatment in urge urinary incontinence or mixed urinary incontinence. It tends to be more effective if urge symptoms are mild.

For further information regarding the management of Urinary Incontinence, please refer to Disease Algorithm for the Treatment Guideline.